Accumulate Caplin Point Laboratories; target of Rs 1675: Asit C Mehta
Asit C Mehta recommended accumulate rating on Caplin Point Laboratories with a target price of Rs 1675 in its research report dated April 25 2024.
Stay updated with breaking news from Caplin Steriles. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Asit C Mehta recommended accumulate rating on Caplin Point Laboratories with a target price of Rs 1675 in its research report dated April 25 2024.
As the final market day of FY23-24 concluded, Indian markets experienced one of their best years, with the Nifty ranking among the top-performing markets in Asia, yielding nearly 29% USD return (second only to Japan). Conversely, China and Hong Kong faced significant underperformance.
In a week marked by fluctuations, the benchmark indices, Sensex and Nifty, managed to recover from earlier losses, concluding the week with marginal gains.
On Wednesday, 2019 stocks advanced, 1683 declined and 126 remained unchanged, with an advance decline ratio of 1.19 on the Bombay Stock Exchange (BSE), indicating positive closing of stocks in broader markets.
Get latest articles and stories on Business at LatestLY. New Delhi [India], September 28: Doceree, the leading global network of physician-only platforms for programmatic messaging, today announced a USD 35 million Series B round led by Creaegis, the leading digital and technology investment firm. Existing investors, Eight Roads Ventures, and F-Prime Capital, also participated in the round. Business News | Doceree Raises USD 35 Million in Series B Funding, Led by Creaegis with Participation from Eight Roads Ventures and F-Prime Capital.